SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonalds shares sold off after management warned that sticky inflation and subdued restaurant traffic may persist, while its new growth plan and franchise investment raised concerns about near-term costs and returns. Traders are divided between viewing the outlook and consumer value pressures as ongoing headwinds and seeing the sharp decline and oversold conditions as a buying opportunity.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Vikings proposed stock-and-convertible-note financing, following encouraging VK2735 obesity-drug maintenance results, is driving debate: critics see dilution and poor timing as a drag on momentum, while supporters say the funding strengthens the companys ability to advance the drug and negotiate from a position of strength. Traders remain focused on the trial data and speculate about a potential partnership or buyout, neither of which is confirmed.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

Coreturas selection of BlackBerrys Alloy Kore platform as its vehicle software foundationthe products first design win and a major addition to QNXs royalty backlogis driving attention alongside the upcoming earnings report. Traders see it as validation of QNXs growth potential, while others question how quickly the backlog will translate into revenue and whether earnings guidance will show meaningful progress.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Metas Muse personal AI agent and the Meta Connect showcase are driving attention, with traders focused on early adoption, potential commerce integrations, and whether the product can become a meaningful source of growth. Optimism over Metas consumer-AI prospects and analyst upgrades competes with concerns about monetization, privacy, heavy AI spending, and a possible sell-the-news reaction after the stocks sharp run.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unusual call-option activity and speculation about a possible Unity buyout are driving attention, with traders also watching Metas VR announcements as a potential catalyst. The acquisition claims are unverified, and some traders argue the options activity may reflect hedging or call sales rather than bullish bets.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

An FDA advisory panel voted in favor of GRAILs Galleri multi-cancer blood test, prompting bullish reactions and speculation about short covering. Traders also note that the panel recommendation is nonbinding and that final FDA approval, labeling, and reimbursement remain uncertain.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

FDA scrutiny of GLP-1 weight-loss offerings and concerns about compounding compliance are weighing on Hims & Hers, with traders debating whether the regulatory risks outweigh its Australia expansion and longer-term peptide opportunity. The share prices choppy trading and repeated resistance have also fueled frustration and short-squeeze speculation.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas acquisition-led expansion in defense and autonomous systems is a major discussion point, with bulls seeing a broader integrated platform and skeptics citing dilution, integration risk, and a lack of organic contract updates. Traders are also focused on the stocks difficulty holding above the $7.50$8 area, debating whether heavy short interest could fuel a squeeze or keep the shares range-bound.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

GOOGs selloff is drawing debate over whether rising yields and rate-hike fears are weighing on tech broadly, alongside concerns that Metas Muse and other AI rivals could erode Googles search and advertising position. Some traders view the decline as a buying opportunity, while others see the competitive and spending risks as reasons for further weakness.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

UPST is drawing attention amid a sharp, persistent selloff, with traders focused on its sensitivity to interest rates and credit conditions and debating concerns about its convertible debt and short interest. The mood is largely bearish, though some investors point to the CEOs share purchase, expanding funding and lending partnerships, and potential bank charter as reasons for optimism.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What Shattuck Labs Stock Topped the Market on Monday

Key PointsOne of them initiated coverage...

Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy?

Does Shattuck Labs, Inc. (STTK) have what it takes to be a top stock pick for momentum investors? Let's find out.

Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade

The consensus price target hints at an 85.3% upside potential for Shattuck Labs (STTK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday

Key PointsHe was encouraged by the progress of the company's SL-325...

What's Going On With Shattuck Labs Stock Wednesday?

Shattuck Labs ($STTK) shares fluctuate after pricing a $75M public offering at $4.00/share. Get the latest stock updates here.read more...

Why Is Shattuck Labs Stock Trading Lower On Monday?

Shattuck Labs' stock tumbles after Phase 1 SL-325 data release despite analyst upgrades, a Buy consensus rating, and progress in IBD treatment.read more...

AI Gold Rush and Global Healthcare Deals Erupt

Investor attention continues shifting toward companies positioned at the intersection of artificial intelligence, biotechnology, defense technology, healthcare infrastructure, and digital transformation. $TGNT, $NCRA, $FRSX, $VWAV, $WOK, $STTK

Shattuck Labs (STTK) to Release Earnings on Thursday

Shattuck Labs (NASDAQ:STTK) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-shattuck-labs-inc-stock...

Shattuck Labs (NASDAQ:STTK) Coverage Initiated by Analysts at Cantor Fitzgerald

Cantor Fitzgerald started coverage on shares of Shattuck Labs in a research report on Monday. They set an "overweight" rating on the stock...

Shattuck Labs (NASDAQ:STTK) Hits New 1-Year High - Time to Buy?

Shattuck Labs (NASDAQ:STTK) Sets New 1-Year High - Here's What Happened...

Shattuck Labs, Inc. is a clinical-stage biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.

Shattuck Labs Inc

GXO Logistics, Momentus, Shattuck Labs: 3 Stocks Retail Investors Are Most Bullish On Today 

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

STTK Shattuck Labs Inc

Fundamentals

Latest STTK News